B2M and hypertensive nephropathy: The present meta-analysis indicated that breviscapine injection can reduce 24-hour urinary protein and the urinary beta-2-microglobulin; a reduction in urinary protein may contribute towards the renal protective effect of breviscapine injection in patients with hypertensive nephropathy.